Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with DSM-IV diagnosis of schizophrenia or schizo-affective disorder for whom antipsychotic monotherapy is indicated.
Subjects must be free from an acute exacerbation of psychosis for at least 3 months prior to screening.
Current Clinical Global Impression (CGI) of Severity of Illness score ≤ 3.
You may not be if
Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, neurological, or allergic disease (including drug allergies, but excluding untreated, asymptomatic, seasonal allergies at time of dosing).
Evidence or history of a primary DSM-IV axis I diagnosis other than schizophrenia or schizoaffective disorder.
Any condition possibly affecting drug absorption (e.g., gastrectomy).
